A murine model of Cryptococcus gattii meningoencephalitis

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 6, 2012, Pages 1432-1438

  Thompson, George R ^a   Wiederhold, Nathan P ^b,c   Najvar, Laura K ^b   Bocanegra, Rosie ^b   Kirkpatrick, William R ^b   Graybill, John R ^b   Patterson, Thomas F ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

C. gattii; Cryptococcal meningoencephalitis; Cryptococcus neoformans; Fluconazole; Posaconazole

Indexed keywords

FLUCONAZOLE; POSACONAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCAL MENINGOENCEPHALITIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; FUNGAL VIRULENCE; HISTOPATHOLOGY; INOCULATION; MENINGOENCEPHALITIS; MOUSE; NONHUMAN; SURVIVAL; TREATMENT RESPONSE;

ANIMALS; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; BRAIN; COLONY COUNT, MICROBIAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; FLUCONAZOLE; HISTOCYTOCHEMISTRY; MENINGOENCEPHALITIS; MICE; MICE, INBRED ICR; SURVIVAL ANALYSIS; TRIAZOLES;

EID: 84861108451     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks060     Document Type: Article

References (19)

1. Kidd SE, Hagen F, Tscharke RL et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 2004; 101: 17258-63.
2. Sorrell TC. Cryptococcus neoformans variety gattii. Med Mycol 2001; 39: 155-68.
3. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984; 120: 123-30.
4. Torres-Rodriguez JM, Morera Y, Baro T et al. Pathogenicity of Cryptococcus neoformans var. gattii in an immunocompetent mouse model. Med Mycol 2003; 41: 59-63.
5. Fraser JA, Giles SS, Wenink EC et al. Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 2005; 437: 1360-4.
6. Krockenberger MB, Malik R, Ngamskulrungroj P et al. Pathogenesis of pulmonary Cryptococcus gattii infection: a rat model. Mycopathologia 2010; 170: 315-30.
7. Driver JA, Saunders CA, Heinze-Lacey B et al. Cryptococcal pneumonia in AIDS: is cryptococcal meningitis preceded by clinically recognizable pneumonia? J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 168-71.
8. Thompson GR III, Wiederhold NP, Fothergill AW et al. Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans. Antimicrob Agents Chemother 2009; 53: 309-11.
9. Ito-Kuwa S, Nakamura K, Aoki S et al. Serotype identification of Cryptococcus neoformans by multiplex PCR. Mycoses 2007; 50: 277-81.
10. Meyer W, Aanensen DM, Boekhout T et al. Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol 2009; 47: 561-70.
11. Diamond DM, Bauer M, Daniel BE et al. Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis. Antimicrob Agents Chemother 1998; 42: 528-33.
12. Ding JC, Bauer M, Diamond DM et al. Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis. Antimicrob Agents Chemother 1997; 41: 1589-93.
13. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press, 1996.
14. Vance AM. The use of the mucicarmine stain for a rapid presumptive identification of Cryptococcus from culture. Am J Med Technol 1961; 27: 125-8.
15. Mitchell DH, Sorrell TC, Allworth AM et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995; 20: 611-6.
16. Byrnes EJ III, Li W, Lewit Y et al. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog 2010; 6: e1000850.
17. Ngamskulrungroj P, Serena C, Gilgado F et al. Global VGIIa isolates are of comparable virulence to the major fatal Cryptococcus gattii Vancouver Island outbreak genotype. Clin Microbiol Infect 2011; 17: 251-8.
18. Hospenthal DR, Bennett JE. Persistence of cryptococcomas on neuroimaging. Clin Infect Dis 2000; 31: 1303-6.
19. Brouwer AE, Teparrukkul P, Pinpraphaporn S et al. Baseline correlation and comparative kinetics of cerebrospinal fluid colony-forming unit counts and antigen titers in cryptococcal meningitis. J Infect Dis 2005; 192: 681-4.